AsOf

Recorded or changed on this day 2026-11-08

851–900 of 46,526 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 6,017,000,000 United States dollar
AbbVie cash and equivalents: 6,017,000,000 United States dollar, claim clm_BBD4856469BA · ended · superseded by clm_B9988D4C4506 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 938,000,000 United States dollar
AbbVie quarterly net income: 938,000,000 United States dollar, claim clm_BC27B55DAB48 · ended · superseded by clm_48C26099DBC0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 1,596,000,000 United States dollar
AbbVie quarterly operating income: 1,596,000,000 United States dollar, claim clm_BC38E2A501A2 · ended · superseded by clm_69DD4A7597DD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 8,278,000,000 United States dollar
AbbVie quarterly revenue: 8,278,000,000 United States dollar, claim clm_BDC07E3C1093 · ended · superseded by clm_EF6AEA6051C0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · -2,921,000,000 United States dollar
AbbVie total equity: -2,921,000,000 United States dollar, claim clm_BEB3B81B5726 · ended · superseded by clm_690948A561DC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 27,169,000,000 United States dollar
AbbVie total assets: 27,169,000,000 United States dollar, claim clm_BF8527D581D8 · ended · superseded by clm_81724D6111B8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 2,768,000,000 United States dollar
AbbVie quarterly operating income: 2,768,000,000 United States dollar, claim clm_C0D9B2A2E414 · ended · superseded by clm_FD718C31F784 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · net income · 1,774,000,000 United States dollar
AbbVie net income: 1,774,000,000 United States dollar, claim clm_C1C38D8E4FB1 · ended · superseded by clm_E3B87E01B082 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 5,475,000,000 United States dollar
AbbVie quarterly revenue: 5,475,000,000 United States dollar, claim clm_C287D4F05535 · ended · superseded by clm_9DB567EABED1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,588,518,764 shares
AbbVie shares outstanding: 1,588,518,764 shares, claim clm_C2C5ABA39CC8 · ended · superseded by clm_A4E4164393FB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 3,831,000,000 United States dollar
AbbVie quarterly operating income: 3,831,000,000 United States dollar, claim clm_C42D4D3906A5 · ended · superseded by clm_837AACDD66BC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 6,469,000,000 United States dollar
AbbVie total equity: 6,469,000,000 United States dollar, claim clm_C5F4EFA54CAC · ended · superseded by clm_05B8B5516E3C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · operating income · 6,383,000,000 United States dollar
AbbVie operating income: 6,383,000,000 United States dollar, claim clm_C605181FAEA0 · ended · superseded by clm_CDA568F800DA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,767,175,532 shares
AbbVie shares outstanding: 1,767,175,532 shares, claim clm_C6A9C2ACDF37 · ended · superseded by clm_030FB734CC46 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · revenue · 58,054,000,000 United States dollar
AbbVie revenue: 58,054,000,000 United States dollar, claim clm_C6FBA5E61236 · ended · superseded by clm_94FBAE0710ED · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 13,130,000,000 United States dollar
AbbVie cash and equivalents: 13,130,000,000 United States dollar, claim clm_C708C0B4DD61 · ended · superseded by clm_A6BEF465151C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 11,832,000,000 United States dollar
AbbVie cash and equivalents: 11,832,000,000 United States dollar, claim clm_C88762AEF762 · ended · superseded by clm_9196480FD2FF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 6,098,000,000 United States dollar
AbbVie cash and equivalents: 6,098,000,000 United States dollar, claim clm_C8B5152DE66D · ended · superseded by clm_D466A4BBCCE0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · net income · 5,309,000,000 United States dollar
AbbVie net income: 5,309,000,000 United States dollar, claim clm_C95C497479DE · ended · superseded by clm_E37E3A79E8BD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 5,172,000,000 United States dollar
AbbVie cash and equivalents: 5,172,000,000 United States dollar, claim clm_CAA6A1B515D0 · ended · superseded by clm_B886C897B1F0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 8,479,000,000 United States dollar
AbbVie quarterly revenue: 8,479,000,000 United States dollar, claim clm_CB0B88225C13 · ended · superseded by clm_A47008E5C136 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly revenue · 12,225,000,000 United States dollar
AbbVie quarterly revenue: 12,225,000,000 United States dollar, claim clm_CBFCA4B48C56 · ended · superseded by clm_593BEB422FF1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 7,289,000,000 United States dollar
AbbVie cash and equivalents: 7,289,000,000 United States dollar, claim clm_CC9157DEB0B1 · ended · superseded by clm_239801DFD565 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 136,463,000,000 United States dollar
AbbVie total assets: 136,463,000,000 United States dollar, claim clm_CD090548C18D · ended · superseded by clm_A320A5717609 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
AbbVie · SEC CIK · 0001551152
AbbVie SEC CIK: 0001551152, claim clm_CD48BB22552C · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · operating income · 12,983,000,000 United States dollar
AbbVie operating income: 12,983,000,000 United States dollar, claim clm_CDA568F800DA · ended · superseded by clm_741BF6260BB0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 9,223,000,000 United States dollar
AbbVie cash and equivalents: 9,223,000,000 United States dollar, claim clm_CE1D0788C2C4 · ended · superseded by clm_78885045199F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 3,400,000,000 United States dollar
AbbVie quarterly operating income: 3,400,000,000 United States dollar, claim clm_CE5BF9768804 · ended · superseded by clm_F92C29C59D1E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly operating income · 4,603,000,000 United States dollar
AbbVie quarterly operating income: 4,603,000,000 United States dollar, claim clm_CEA4039DB60E · ended · superseded by clm_C0D9B2A2E414 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,590,861,812 shares
AbbVie shares outstanding: 1,590,861,812 shares, claim clm_CF64F485A489 · ended · superseded by clm_C2C5ABA39CC8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,583,729,114 shares
AbbVie shares outstanding: 1,583,729,114 shares, claim clm_CFC2CCBD26FA · ended · superseded by clm_AC2DD135BFA3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 5,100,000,000 United States dollar
AbbVie cash and equivalents: 5,100,000,000 United States dollar, claim clm_CFE5A45B27A0 · ended · superseded by clm_94C338ACD4BE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 924,000,000 United States dollar
AbbVie quarterly net income: 924,000,000 United States dollar, claim clm_D086E009B1C1 · ended · superseded by clm_16B89E250F5D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · operating income · 9,384,000,000 United States dollar
AbbVie operating income: 9,384,000,000 United States dollar, claim clm_D0B092E67442 · ended · superseded by clm_386A79CBE5AB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 15,994,000,000 United States dollar
AbbVie total equity: 15,994,000,000 United States dollar, claim clm_D0C776D4C6FD · ended · superseded by clm_79A5901E7AEB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · 12,866,000,000 United States dollar
AbbVie total equity: 12,866,000,000 United States dollar, claim clm_D0CAEDA52B47 · ended · superseded by clm_DA2BBA888E3B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 6,711,000,000 United States dollar
AbbVie cash and equivalents: 6,711,000,000 United States dollar, claim clm_D0F44FB1629D · ended · superseded by clm_F77382A19536 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · revenue · 56,197,000,000 United States dollar
AbbVie revenue: 56,197,000,000 United States dollar, claim clm_D102FEEF7A89 · ended · superseded by clm_C6FBA5E61236 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · shares outstanding · 1,504,216,327 shares
AbbVie shares outstanding: 1,504,216,327 shares, claim clm_D17ED6882DEF · ended · superseded by clm_29853AC1B7D4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 3,010,000,000 United States dollar
AbbVie quarterly net income: 3,010,000,000 United States dollar, claim clm_D228AC43E824 · ended · superseded by clm_22AD188AF61F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 5,901,000,000 United States dollar
AbbVie cash and equivalents: 5,901,000,000 United States dollar, claim clm_D328E96523A5 · ended · superseded by clm_06BF7AB6F5F9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 53,050,000,000 United States dollar
AbbVie total assets: 53,050,000,000 United States dollar, claim clm_D36BDE4DBD80 · ended · superseded by clm_DCE037E09A9F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 12,814,000,000 United States dollar
AbbVie cash and equivalents: 12,814,000,000 United States dollar, claim clm_D3C029303D23 · ended · superseded by clm_5C0E4B389278 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 53,855,000,000 United States dollar
AbbVie total assets: 53,855,000,000 United States dollar, claim clm_D42809778327 · ended · superseded by clm_5BFD83100796 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 26,699,000,000 United States dollar
AbbVie total assets: 26,699,000,000 United States dollar, claim clm_D450CCC758EE · ended · superseded by clm_D42809778327 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 8,521,000,000 United States dollar
AbbVie cash and equivalents: 8,521,000,000 United States dollar, claim clm_D466A4BBCCE0 · ended · superseded by clm_C88762AEF762 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total assets · 28,252,000,000 United States dollar
AbbVie total assets: 28,252,000,000 United States dollar, claim clm_D47B65E8AFA3 · ended · superseded by clm_7B4C916FCBA1 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
AbbVie · operating income · 15,075,000,000 United States dollar
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.
AbbVie · fiscal year end · 12-31
AbbVie fiscal year end: 12-31, claim clm_D5837D9B7367 · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · cash and equivalents · 9,303,000,000 United States dollar
AbbVie cash and equivalents: 9,303,000,000 United States dollar, claim clm_D8002DD7DB3E · ended · superseded by clm_5A3AC951CCFF · 1 source (1 primary) · conf 0.95

What the statuses mean